HEALTH.2011.2.4.1-2
HEALTH.2011.2.4.1-2
3 projects · €8,998,329 total EU contribution (project-level) · 31 participating organizations · 12 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€8,998,329
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (7)
- AT (6)
- UK (4)
- France (3)
- BE (2)
- HU (2)
- Netherlands (2)
- AU (1)
- CZ (1)
- Spain (1)
- IL (1)
- Italy (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- INSERM2 projects · FR
- UNIBA2 projects · IT
- AMC1 projects · NL
- Alcedis1 projects · DE
- Cellzome1 projects · DE
- CEMIT1 projects · AT
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN1 projects · DE
- CYC1 projects · UK
- CENTRAL HOSPITAL OF SOUTHERN PEST NATIONAL INSTITUTE OF HEMATOLOGY AND INFECTIOUS DISEASE1 projects · HU
- EMERGENTEC BIODEVELOPMENT GMBH1 projects · AT
- ERASMUS MC1 projects · NL
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1 projects · UK
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MYR · 278706 | FP7 | €2,999,498 | €3,923,510 | Details |
Ovarian Cancer Therapy – Innovative Models Prolong Survival OCTIPS · 279113 | FP7 | €2,999,302 | €3,964,947 | Details |
OPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma OPTATIO · 278570 | FP7 | €2,999,529 | €4,284,453 | Details |